This month’s top news stories.
In a recent study, severe COVID-19 made up 8% of cases among neonates aged less than 28 days.
This case study analyzes variants of majocchi granuloma and potential treatment.
The US Food and Drug Administration recently outlined the risks and symptoms of Cronobacter infection in young infants, and how to reduce risk of infection.
New 16-week data from the SPROUT trial show the PDE4 inhibitor may be highly efficacious in children and adolescents.
At the 2022 AAP National Conference & Exhibition, a practitioner shares her expertise on how to communicate with families to manage a child’s eating disorder (ED) and review practical strategies while increasing patient and family satisfaction.
At the 2022 American Academy of Pediatrics National Conference & Exhibition, research was presented on which children are at high risk of severe COVID-19.
As COVID-19 continues to spread, vaccinations remain available to protect children from severe disease, hospitalization, and death.
In a recent study, investigators found that children from socioeconomically depraved families were more likely to be hospitalized from COVID-19.
At the 2022 AAP National Conference & Exhibition, a presenter delves into diagnosis and management of common and uncommon skin rashes in newborns.
New research suggests the sleep quality of caregivers and patients with atopic dermatitis (inadequately-controlled with topical therapies) may improve with dupilumab treatment.